Hazard
288 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 288 sterility risk recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 50 (17%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all sterility risk recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Martin Avenue Pharmacy is voluntarily recalling Hydroxyzine hydrochloride 25 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling hyaluronidase injection solution due to quality control issues that may compromise sterility.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Quad mix, due to quality control issues that may compromise sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix injectable vials because quality control observations during an FDA inspection raised concerns about sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including phentolamine mesylate, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Quad mix 2, due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T102 injectable vials because quality control issues identified during an FDA inspection may compromise sterility.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Tri-mix ST9-B, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Atropine sulfate 1 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Quad Mix injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Diazepam, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including chlorhexidine gluconate ophthalmic solution, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling dihydroergotamine mesylate injections due to quality control issues that may compromise sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Prednisolone acetate 50 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T106 injectable vials because FDA inspection observations raised concerns about sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling all compounded sterile preparations within expiry due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded morphine sulfate injectables due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix ST9-A injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including morphine/bupivacaine, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Methylcobalamin 10 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Atropine sulfate 0.5% ophthalmic solution due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling PGE 4 injectable vials because quality control issues identified during an FDA inspection present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix ST2 injectable vials because quality control issues identified during an FDA inspection may compromise sterility.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T50 injectable vials due to quality control observations that present a risk to sterility assurance.